4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD | Market Cap | 3.32B +1,948.2% |
| Revenue (ttm) | 5.81M -0.8% |
| Net Income | -172.93M |
| EPS | -0.41 |
| Shares Out | 589.36M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,126,671 |
| Average Volume | 8,806,594 |
| Open | 5.78 |
| Previous Close | 5.64 |
| Day's Range | 5.67 - 5.98 |
| 52-Week Range | 0.23 - 7.55 |
| Beta | 2.21 |
| RSI | 62.27 |
| Earnings Date | May 27, 2026 |
About 4DMedical
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non‑invasive respiratory imaging solution using four‑dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of poten... [Read more]
Financial Performance
In fiscal year 2025, 4DMedical's revenue was 5.85 million, an increase of 55.91% compared to the previous year's 3.75 million. Losses were -30.07 million, -16.42% less than in 2024.
Financial StatementsNews
4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union
In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 30, 2...
4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging
Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health,...
4DMedical's CT:VQ™ receives FDA 510(k) clearance; First-and-only CT-based VQ technology
Medicare confirms reimbursement, unlocking nationwide access to non-contrast ventilation–perfusion imaging from routine chest CT LOS ANGELES , Sept. 4, 2025 /PRNewswire/ -- 4DMedical, a leader in adva...